Published on December 14, 2017
As part of our coverage from the 2017 American Society of Hematology (ASH) annual meeting, A “super panel” of MPN experts Dr. Mark Heaney, Dr. Rami Komrokji, Dr. Ruben Mesa, Dr. Jamile Shammo, as well as Andrew Schorr, gathered to discuss the latest news and developments related to research and treatment of myeloproliferative neoplasms (MPNs). The experts all shared their perspective on the “headlines” from this year’s meeting, including updates on JAK inhibitors in development, news on interferon, diagnostic testing, the story that somatic mutations tell, and the overwhelming interest in the study of MPNs. Watch to learn the latest news in MPN research.
Sponsored by Incyte Corporaton.